J. Adachi, S. Matsushita, N. Yoshioka, R. Funae, T. Fujita et al., Plasma phosphatidylcholine hydroperoxide as a new marker of oxidative stress in alcoholic patients, The Journal of Lipid Research, vol.45, issue.5, pp.967-71, 2004.
DOI : 10.1194/jlr.M400008-JLR200

V. Afonso, R. Champy, D. Mitrovic, and A. Lomri, Radicaux libres d??riv??s de??l'oxyg??ne et??superoxydes dismutases: r??le dans??les??maladies rhumatismales, Revue du Rhumatisme, vol.74, issue.7, pp.636-679, 2007.
DOI : 10.1016/j.rhum.2006.12.009

. Agence-france-presse, La Sécu a dépensé 10 milliards d'euros pour le diabète en 2010, Le Point, vol.29, issue.06, 2011.

B. Ahren, Use of DPP-4 inhibitors in type 2 diabetes: focus on sitagliptin, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, vol.3, pp.31-41, 2010.
DOI : 10.2147/DMSO.S7327

K. Arab and J. Steghens, Plasma lipid hydroperoxides measurement by an automated xylenol orange method, Analytical Biochemistry, vol.325, issue.1, pp.158-63, 2004.
DOI : 10.1016/j.ab.2003.10.022

A. Astrup, The Role of Dietary Fat in Obesity, Seminars in Vascular Medicine, vol.5, issue.01, pp.40-47, 2005.
DOI : 10.1055/s-2005-871740

A. Astrup, The Role of Dietary Fat in Obesity, Seminars in Vascular Medicine, vol.5, issue.01, p.664, 2005.
DOI : 10.1055/s-2005-871740

A. Avignon and S. Picard, Lipotoxicité et régulation glycémique, Diabetes & Metabolism, vol.25, pp.275-82, 1999.

M. Beljean-leymarie, L. Lemauviel, and E. Bruna, Chromatographic determination of plasma malondialdehyde, Ann Biol Clin, vol.51, p.436, 1993.

K. Bouzakri, H. Koistinen, and J. Zierath, Molecular Mechanisms of Skeletal Muscle Insulin Resistance in Type 2 Diabetes, Current Diabetes Reviews, vol.1, issue.2, pp.167-74, 2005.
DOI : 10.2174/1573399054022785

L. Brasseur, P. Thérond, and A. Legrand, Pouvoir antioxydant total du plasma, Act Pharm Biol Clin, vol.8, pp.239-283, 1995.

M. Brownlee, H. Vlassara, and A. Cerami, Nonenzymatic Glycosylation and the Pathogenesis of Diabetic Complications, Annals of Internal Medicine, vol.101, issue.4, pp.527-564, 1984.
DOI : 10.7326/0003-4819-101-4-527

M. Brownlee, Biochemistry and molecular cell biology of diabetic complications, Nature, vol.414, issue.6865, pp.813-833, 2001.
DOI : 10.1038/414813a

E. Cadenas and J. Daries, Mitochondrial free radical generation, oxidative stress, and aging. Free radical, Biol Med, vol.29, pp.222-252, 2000.

A. Ceriello, P. Dello-russo, P. Amstad, and P. Cerutti, High Glucose Induces Antioxidant Enzymes in Human Endothelial Cells in Culture: Evidence Linking Hyperglycemia and Oxidative Stress, Diabetes, vol.45, issue.4, pp.471-478, 1996.
DOI : 10.2337/diab.45.4.471

A. Cerellio, N. Bortolotti, and M. Pirisi, Total Plasma Antioxidant Capacity Predicts Thrombosis-Prone Status in NIDDM Patients, Diabetes Care, vol.20, issue.10, pp.1589-93, 1997.
DOI : 10.2337/diacare.20.10.1589

A. Cerellio, N. Bortolotti, and A. Crescentini, Antioxidant defences are reduced during the oral glucose tolerance test in normal and non-insulin-dependent diabetic subjects, European Journal of Clinical Investigation, vol.38, issue.1, pp.329-362, 1998.
DOI : 10.1006/abbi.1994.1297

M. Circu and T. Aw, Reactive oxygen species, cellular redox systems, and apoptosis, Free Radical Biology and Medicine, vol.48, issue.6
DOI : 10.1016/j.freeradbiomed.2009.12.022

S. Dal, Le stress oxydant, diabète et complications. CEED, 2007.

I. Dalle-donne, R. Rossi, R. Colombo, D. Giustarini, and A. Milzani, Biomarkers of Oxidative Damage in Human Disease, Clinical Chemistry, vol.52, issue.4, pp.601-623, 2006.
DOI : 10.1373/clinchem.2005.061408

G. Davi and G. Ciabattoni, In Vivo Formation of 8-Iso-Prostaglandin F2?? and Platelet Activation in Diabetes Mellitus : Effects of Improved Metabolic Control and Vitamin E Supplementation, Circulation, vol.99, issue.2, pp.224-233, 1999.
DOI : 10.1161/01.CIR.99.2.224

M. Davies, S. Fu, H. Wang, and R. Dean, Stable markers of oxidant damage to proteins and their application in the study of human disease, Free Radical Biology and Medicine, vol.27, issue.11-12, pp.1151-61, 1999.
DOI : 10.1016/S0891-5849(99)00206-3

T. Davis, I. Stratton, C. Fox, R. Holman, and R. U. Turner, U.K. Prospective Diabetes Study 22: Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM, Diabetes Care, vol.20, issue.9, pp.1435-1476, 1997.
DOI : 10.2337/diacare.20.9.1435

URL : https://hal.archives-ouvertes.fr/in2p3-00119229

D. Del-rio, A. Stewart, and N. Pellegrini, A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress, Nutrition, Metabolism and Cardiovascular Diseases, vol.15, issue.4, pp.316-344, 2005.
DOI : 10.1016/j.numecd.2005.05.003

L. Deleve and N. Kaplowitz, Glutathione metabolism and its role in hepatotoxicity, Pharmacology & Therapeutics, vol.52, issue.3, pp.287-305, 1991.
DOI : 10.1016/0163-7258(91)90029-L

A. Dresner, D. Laurent, and M. Marcucci, Effects of free fatty acids on glucose transport and IRS-1???associated phosphatidylinositol 3-kinase activity, Journal of Clinical Investigation, vol.103, issue.2, pp.253-262, 1999.
DOI : 10.1172/JCI5001

W. Dröde, Free radicals in the physiological control of cell function, Physiol Rev, vol.82, pp.47-95, 2002.

M. Elashoff, A. Matveyenko, B. Gier, R. Elashoff, and P. Butler, Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1???Based Therapies, Gastroenterology, vol.141, issue.1, pp.150-156, 2011.
DOI : 10.1053/j.gastro.2011.02.018

F. Andreelli and B. Viollet, Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state, J Clin Invest, vol.120, pp.2355-69, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00495746

R. Franco, O. Schoneveld, A. Pappa, and M. Panayiotidis, The central role of glutathione in the pathophysiology of human diseases, Archives of Physiology and Biochemistry, vol.134, issue.4-5, pp.234-58, 2007.
DOI : 10.1182/blood-2003-12-4299

I. Fridovich, Superoxide Radical and Superoxide Dismutases, Annual Review of Biochemistry, vol.64, issue.1, pp.97-112, 1995.
DOI : 10.1146/annurev.bi.64.070195.000525

C. Furtado-de-souza, M. Dalzochio, F. De-oliveira, J. Gross, and C. Leitao, Glucose tolerance status is a better predictor of diabetes and cardiovascular outcomes than metabolic syndrom : a prospective cohort study, Diabetol Metab Syndr, vol.4, pp.4-25, 2012.

C. Gay and J. Gebicki, Measurement of protein and lipid hydroperoxides in biological systems by the ferric???xylenol orange method, Analytical Biochemistry, vol.315, issue.1, pp.29-35, 2003.
DOI : 10.1016/S0003-2697(02)00606-1

I. Giardino, D. Edelstein, and M. Brownlee, BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells., Journal of Clinical Investigation, vol.97, issue.6, pp.1422-1430, 1996.
DOI : 10.1172/JCI118563

P. Gillery, G. Dumont, and A. Vassault, Evaluation of GHb Assays in France by National Quality Control Surveys, Diabetes Care, vol.21, issue.2, pp.265-70, 1998.
DOI : 10.2337/diacare.21.2.265

J. Girard, Rôle des acides gras libres dans l'insulino-résistance au cours du diabète non-insulino-dépendant, Diabete Metab, vol.21, pp.79-88, 1995.

J. Girard, R??le des acides gras libres dans la s??cr??tion et l???action de l???insuline : m??canismes de la lipotoxicit??, m??decine/sciences, vol.19, issue.8-9, pp.827-860, 2003.
DOI : 10.1051/medsci/20031989827

J. Girard, The incretins: From the concept to their use in the treatment of type??2 diabetes. Part A: Incretins: Concept and physiological functions, Diabetes & Metabolism, vol.34, issue.6, pp.550-559, 2008.
DOI : 10.1016/j.diabet.2008.09.001

A. Greismacher, M. Kindhauser, and S. Andert, Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus, The American Journal of Medicine, vol.98, issue.5, pp.469-75, 1995.
DOI : 10.1016/S0002-9343(99)80347-7

K. Griendling, D. Sorescu, and M. Ushio-fukai, NAD(P)H Oxidase : Role in Cardiovascular Biology and Disease, Circulation Research, vol.86, issue.5, pp.494-501, 2000.
DOI : 10.1161/01.RES.86.5.494

J. Gutteridge, J. Stocks, and T. Dormandy, Thiobarbituric acid-reacting substances derived from autoxidizing linoleic and linolenic acids, Analytica Chimica Acta, vol.70, issue.1, pp.107-118, 1974.
DOI : 10.1016/S0003-2670(01)82915-9

J. Gutteridge, Invited Review Free Radicals in Disease Processes: A Compilation of Cause and Consequence, Free Radical Research Communications, vol.70, issue.3, pp.598-620, 1992.
DOI : 10.1097/00003226-199004000-00013

J. Haddad, Oxygen-sensing mechanisms and the regulation of redox-responsive transcription factors in development and pathophysiology, Respiratory Research, vol.17, issue.103, p.26, 2002.
DOI : 10.1186/rr190

S. Haffner, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso, Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction, New England Journal of Medicine, vol.339, issue.4, pp.229-263, 1998.
DOI : 10.1056/NEJM199807233390404

B. Halliwell and J. Gutteridge, Free radicals in biology and medicine, second edition, Free Radical Biology and Medicine, vol.10, issue.6, 1989.
DOI : 10.1016/0891-5849(91)90055-8

B. Halliwell and J. Gutteridge, Free radicals in biology and medicine

J. Hare, Nitroso???Redox Balance in the Cardiovascular System, New England Journal of Medicine, vol.351, issue.20, pp.2112-2126, 2004.
DOI : 10.1056/NEJMe048269

H. Autorité and D. Santé, Comission de la transparence du Victoza 6mg/ml, solution injectable en stylo préremli, 2009.

J. Hodge, Dehydrated Foods, Chemistry of Browning Reactions in Model Systems, Journal of Agricultural and Food Chemistry, vol.1, issue.15, pp.928-971, 1953.
DOI : 10.1021/jf60015a004

B. Hudson, T. Wendt, and L. Bucciarelli, Diabetic Vascular Disease: It's All the RAGE, Antioxidants & Redox Signaling, vol.7, issue.11-12, pp.1588-1600, 2005.
DOI : 10.1089/ars.2005.7.1588

J. Hunt, R. Dean, and S. Wolff, Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing, Biochemical Journal, vol.256, issue.1, pp.205-217, 1988.
DOI : 10.1042/bj2560205

I. , K. Health, and R. Ob-epi, Enquête épidémiologique nationale sur le surpoids et l'obésité, 2012.

D. Janero, Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury, Free Radical Biology and Medicine, vol.9, issue.6, pp.515-555, 1990.
DOI : 10.1016/0891-5849(90)90131-2

L. Johanson and L. Borg, A spectrophotometric method for determination of catalase activity in small tissue samples, Analytical Biochemistry, vol.174, issue.1, pp.331-337, 1988.
DOI : 10.1016/0003-2697(88)90554-4

A. Kennedy and T. Lyons, Glycation, oxidation, and lipoxidation in the development of diabetic complications, Metabolism, vol.46, pp.14-21, 1997.
DOI : 10.1016/S0026-0495(97)90311-5

J. Kim, O. Gavrilova, Y. Chen, M. Reitman, and G. Shulman, Mechanism of Insulin Resistance in A-ZIP/F-1 Fatless Mice, Journal of Biological Chemistry, vol.275, issue.12, pp.8456-60, 2000.
DOI : 10.1074/jbc.275.12.8456

G. King and M. Brownlee, THE CELLULAR AND MOLECULAR MECHANISMS OF DIABETIC COMPLICATIONS, Endocrinology and Metabolism Clinics of North America, vol.25, issue.2, pp.255-70, 1996.
DOI : 10.1016/S0889-8529(05)70324-8

E. Kukielka, E. Dicker, and A. Cederbaum, Increased Production of Reactive Oxygen Species by Rat Liver Mitochondria After Chronic Ethanol Treatment, Archives of Biochemistry and Biophysics, vol.309, issue.2, pp.377-86, 1994.
DOI : 10.1006/abbi.1994.1127

O. Kusnik-joinville, A. Weill, P. Ricordeau, and H. Allemand, Diabète traité en France en 2007 : un taux de prévalence proche de 4% et des disparités géographiques croissantes, Bulletin Epidémiologique Hebdomadaire, vol.43, pp.409-429, 2008.

A. Lapillonne, Retard de croissance intra-utérin et devenir à l'âge adulte, Bull Acad Natle Med, vol.195, pp.477-85, 2011.

G. Litherland and H. Hundal, Protein kinase B (PKB/Akt) ? a key regulator of glucose transport?, FEBS, vol.492, pp.199-203, 2001.

W. Malaisse, F. Malaisse-lagae, A. Sener, and C. Hellerström, Participation of endogenous fatty acids in the secretory activity of the pancreatic B-cell, Biochemical Journal, vol.227, issue.3, pp.995-1002, 1985.
DOI : 10.1042/bj2270995

T. Mason, T. Goh, and V. Tchipashvili, Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats, Diabetes, vol.48, issue.3, pp.524-554, 1999.
DOI : 10.2337/diabetes.48.3.524

P. Massion, J. Preiser, and J. Balligand, Les espèces réactives de l'azote : bénéfiques ou délétères ? Nutrition clinique et métabolisme, pp.248-52, 2002.

G. Milne, S. Sanchez, E. Musiek, and J. Morrow, Quantification of F2-isoprostanes as a biomarker of oxidative stress, Nature Protocols, vol.58, issue.1, pp.221-227, 2007.
DOI : 10.1038/nprot.2006.375

S. Moncada, R. Palmer, and E. Higgs, Nitric oxide : physiology, pathophysiology, and pharmacology, Pharmacol Rev, vol.43, pp.109-151, 1991.

V. Monnier, Toward a Maillard reaction theory of aging, Prog Clin Biol Res, vol.304, pp.1-22, 1989.

L. Monnier and E. Mas, Activation of oxidatve stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes

P. Montushi, P. Barnes, and L. Roberts, Isoprostanes: markers and mediators of oxidative stress, The FASEB Journal, vol.18, issue.15, pp.1791-1800, 2004.
DOI : 10.1096/fj.04-2330rev

J. Morrow, T. Harris, and L. Roberts-2nd, Non cyclooxygenase oxidative formation of a series of novel prostaglandins: Analytical ramifications for measurement of eicosanoids, Anal Biochem, vol.181, pp.1-10, 1990.

D. Mulder and T. Water, Skin Autofluorescence, a Novel Marker for Glycemic and Oxidative Stress-Derived Advanced Glycation Endproducts: An Overview of Current Clinical Studies, Evidence, and Limitations, Diabetes Technology & Therapeutics, vol.8, issue.5, pp.523-558, 2006.
DOI : 10.1089/dia.2006.8.523

K. Nakajima, T. Nakano, and A. Tanaka, The oxidative modification hypothesis of atherosclerosis: The comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma, Clinica Chimica Acta, vol.367, issue.1-2, pp.36-47, 2006.
DOI : 10.1016/j.cca.2005.12.013

V. Nair, G. Turner, and R. Oferman, Novel adducts from the modification of nucleic acid bases by malondialdehyde, Journal of the American Chemical Society, vol.106, issue.11, pp.3370-3371, 1984.
DOI : 10.1021/ja00323a061

M. Païta and A. Weill, Les personnes en Affection Longue Durée au 31 décembre, 2007.

J. Pincemail, M. Meurisse, R. Limet, and J. Defraigne, Evaluation du stress oxydant : une réalité pour le médecin généraliste, Poumon, vol.4, pp.148-54, 1999.

V. Poitout and R. Robertson, Minireview: Secondary ??-Cell Failure in Type 2 Diabetes--A Convergence of Glucotoxicity and Lipotoxicity, Endocrinology, vol.143, issue.2, pp.339-381, 2002.
DOI : 10.1210/en.143.2.339

P. Randle, P. Garland, and E. Newsholme, THE GLUCOSE FATTY-ACID CYCLE ITS ROLE IN INSULIN SENSITIVITY AND THE METABOLIC DISTURBANCES OF DIABETES MELLITUS, The Lancet, vol.281, issue.7285, pp.785-789, 1963.
DOI : 10.1016/S0140-6736(63)91500-9

. Ref-diabete-quebec, Alcool et diabète, html Revue prescrire, vol.28, p.664, 2008.

L. Roberts-2nd and J. Morrow, Measurement of F2-isoprostanes as an index of oxidative stress in vivo, Free Radical Biology and Medicine, vol.28, issue.4, pp.505-518, 2000.
DOI : 10.1016/S0891-5849(99)00264-6

A. Saad, G. Virella, and C. Ch, OxLDL immune complexes activate complement and induce cytokine production by MonoMac 6 cells and human macrophages, The Journal of Lipid Research, vol.47, issue.9, pp.1975-83, 2006.
DOI : 10.1194/jlr.M600064-JLR200

E. Salas-vidal, H. Lomeli, S. Castro-obregon, R. Cuervo, D. Escalante-alcalde et al., Reactive Oxygen Species Participate in the Control of Mouse Embryonic Cell Death, Experimental Cell Research, vol.238, issue.1, pp.136-183, 1998.
DOI : 10.1006/excr.1997.3828

B. Shin, J. Huggins, and K. Carraway, Effects of pH, concentration and aging on the malonaldehyde reaction with proteins, Lipids, vol.112, issue.4, pp.229-262, 1972.
DOI : 10.1007/BF02533218

G. Shulman, Cellular mechanisms of insulin resistance, Journal of Clinical Investigation, vol.106, issue.2, 2000.
DOI : 10.1172/JCI10583

D. Slatter, C. Bolton, and A. Bailey, The importance of lipid-derived malondialdehyde in diabetes mellitus, Diabetologia, vol.43, issue.5, pp.550-557, 2000.
DOI : 10.1007/s001250051342

R. Stocker and J. Keaney, Role of Oxidative Modifications in Atherosclerosis, Physiological Reviews, vol.84, issue.4, pp.1381-1478, 2004.
DOI : 10.1152/physrev.00047.2003

G. Suarez, R. Rajaram, K. Bhuyan, A. Oranshy, and J. Goidl, Administration of an aldose reductase inhibitor induces a decrease of collagen fluorescence in diabetic rats., Journal of Clinical Investigation, vol.82, issue.2, pp.624-631, 1988.
DOI : 10.1172/JCI113641

S. Summers, Ceramides in insulin resistance and lipotoxicity, Progress in Lipid Research, vol.45, issue.1, pp.42-72, 2006.
DOI : 10.1016/j.plipres.2005.11.002

K. Suzuki, Y. Ito, T. Inoue, and N. Hamajima, Inverse association of serum carotenoids with prevalence of metabolic syndrome among Japanese, Clinical Nutrition, vol.30, issue.3, pp.369-75, 2011.
DOI : 10.1016/j.clnu.2010.12.006

V. Thallas-bonke, S. Thorpe, M. Coughlan, K. Fukami, F. Yap et al., Inhibition of NADPH Oxidase Prevents Advanced Glycation End Product-Mediated Damage in Diabetic Nephropathy Through a Protein Kinase C-??-Dependent Pathway, Diabetes, vol.57, issue.2, pp.460-469, 2008.
DOI : 10.2337/db07-1119

P. Thérond, M. Couturier, J. Demelier, and F. Lemonnier, Simultaneous determination of the main molecular species of soybean phosphatidylcholine or phosphatidylethanolamine and their corresponding hydroperoxides obtained by lipoxygenase treatment, Lipids, vol.15, issue.3, pp.245-254, 1993.
DOI : 10.1007/BF02536647

D. Tsikas and E. Schwedhelm, Divergence in urinary 8-iso-PGF2?? (iPF2??-III, 15-F2t-IsoP) levels from gas chromatography???tandem mass spectrometry quantification after thin-layer chromatography and immunoaffinity column chromatography reveals heterogeneity of 8-iso-PGF2??, Journal of Chromatography B, vol.794, issue.2, pp.237-55, 2003.
DOI : 10.1016/S1570-0232(03)00457-4

S. Tsimikas, Measures of Oxidative Stress, Clinics in Laboratory Medicine, vol.26, issue.3, pp.571-90, 2006.
DOI : 10.1016/j.cll.2006.06.004

K. Uchida and E. Stadtman, Modification of histidine residues in proteins by reaction with 4-hydroxynonenal., Proceedings of the National Academy of Sciences, vol.89, issue.10, pp.4544-4552, 1992.
DOI : 10.1073/pnas.89.10.4544

R. Unger, How obesity causes diabetes in Zucker diabetic fatty rats, Trends in Endocrinology and Metabolism, vol.8, issue.7, pp.276-82, 1997.
DOI : 10.1016/S1043-2760(97)00094-5

C. Vindis, Etude de l'effet prolifératif du peroxyde d'hydrogène produit par les monoamines oxydases rénales, 2000.

M. Virally, J. Blicklé, J. Girard, S. Halimi, D. Simon et al., Type 2??diabetes mellitus: epidemiology, pathophysiology, unmet needs and??therapeutical perspectives, Diabetes & Metabolism, vol.33, issue.4, pp.231-275, 2007.
DOI : 10.1016/j.diabet.2007.07.001

M. Virally, J. Kevorkian, and P. Guillausseau, Incretines, incrétinomimétiques et inhibiteurs de la DPP-4 : homéostasie glucidique et diabète de type 2, STV, vol.20, pp.453-61, 2008.

B. Waeber and D. Roth, The HOT study : A new step in the management of hypertension?

P. Wardman and L. Candeias, Fenton Chemistry: An Introduction, Radiation Research, vol.145, issue.5, pp.523-554, 1996.
DOI : 10.2307/3579270